---
figid: PMC3989988__gr1
figtitle: De novo serine biosynthesis diverges from glycolysis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Human papillomavirus type 16
pmcid: PMC3989988
filename: gr1.jpg
figlink: /pmc/articles/PMC3989988/figure/fig0005/
number: F1
caption: 'De novo serine biosynthesis diverges from glycolysis. The serine synthesis
  pathway utilises the glycolytic intermediate 3P-glycerate, which is converted by
  PHGDH, PSAT-1, and PSPH into serine. Removal of exogenous serine causes activation
  of its biosynthetic pathway. Serine accumulation accelerates glycolytic flux, although
  allosteric activation of PKM2 by serine. p53, via TIGAR, and TAp73, via G6PD, facilitate
  activation of the PPP, promoting NADPH and nucleotide synthesis. p53-dependent activation
  of p21 induces transient cell cycle arrest, blocking flux to purines, thus maintaining
  GSH synthesis. TAp73 drives glutamine/glutamate conversion by inducing expression
  of GLS-2, thus pushing serine biosynthetic pathway, while it represses intracellular
  ROS controlling COX4i1 subunit expression. Abbreviations: 3P glycerate, glycerate-3-phosphate;
  PHGDH, phosphoglycerate dehydrogenase; PKM2, pyruvate kinase M2; PPP, pentose phosphate
  pathway; ROS, reactive oxygen species; COX4i1, cytochrome C oxidase subunit 4 isoform
  1; G6PD, glucose-6-phosphate dehydrogenase; GLS-2, glutaminase-2; GSH, glutathione;
  PSAT-1, phosphoserine aminotransferase 1; PSPH, phosphoserine phosphatase; TIGAR,
  TP53-inducible glycolysis and apoptosis regulator.'
papertitle: Serine and glycine metabolism in cancer.
reftext: Ivano Amelio, et al. Trends Biochem Sci. 2014 Apr;39(4):191-198.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9637977
figid_alias: PMC3989988__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
redirect_from: /figures/PMC3989988__F1
ndex: 6563d3d8-ded6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3989988__gr1.html
  '@type': Dataset
  description: 'De novo serine biosynthesis diverges from glycolysis. The serine synthesis
    pathway utilises the glycolytic intermediate 3P-glycerate, which is converted
    by PHGDH, PSAT-1, and PSPH into serine. Removal of exogenous serine causes activation
    of its biosynthetic pathway. Serine accumulation accelerates glycolytic flux,
    although allosteric activation of PKM2 by serine. p53, via TIGAR, and TAp73, via
    G6PD, facilitate activation of the PPP, promoting NADPH and nucleotide synthesis.
    p53-dependent activation of p21 induces transient cell cycle arrest, blocking
    flux to purines, thus maintaining GSH synthesis. TAp73 drives glutamine/glutamate
    conversion by inducing expression of GLS-2, thus pushing serine biosynthetic pathway,
    while it represses intracellular ROS controlling COX4i1 subunit expression. Abbreviations:
    3P glycerate, glycerate-3-phosphate; PHGDH, phosphoglycerate dehydrogenase; PKM2,
    pyruvate kinase M2; PPP, pentose phosphate pathway; ROS, reactive oxygen species;
    COX4i1, cytochrome C oxidase subunit 4 isoform 1; G6PD, glucose-6-phosphate dehydrogenase;
    GLS-2, glutaminase-2; GSH, glutathione; PSAT-1, phosphoserine aminotransferase
    1; PSPH, phosphoserine phosphatase; TIGAR, TP53-inducible glycolysis and apoptosis
    regulator.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - G6PD
  - UBL4A
  - DECR1
  - TP53
  - TP63
  - TP73
  - PHGDH
  - GLS2
  - PSPH
  - PKM
  - PKLR
  - SHMT1
  - SHMT2
  - COX4I1
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - SALL1
  - TIGAR
  - G6pd
  - Tp53
  - Phgdh
  - Gls2
  - Psph
  - Pkm
  - Ccne1
  - Shmt1
  - Cox4i1
  - Kras
  - Tigar
  - Trp73
  - G6pdx
  - Decr1
  - Trp53
  - Gnat2
  - Shmt2
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Hbb-bs
---
